ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

L-Nutra Reports First-Ever Study Showing ProLon® Improves Skin Health, Happiness, and Confidence

L-Nutra Inc., a leading nutrition technology company that pioneers the discovery, design, and commercialization of novel nutrition programs that impact cellular rejuvenation and support healthy aging, announced the results of a first-ever study evaluating the impact of its Fasting Mimicking Diet (ProLon®) on skin hydration, texture, and psychological well-being in women. 

The study, which was published in the Journal of Clinical Medicine, is the first randomized controlled trial demonstrating the efficacy of a five-day Fasting Mimicking Diet (FMD) Nutrition protocol on enhancing skin quality, smoothness, hydration, and key components of psychological well-being. Skin health and mental wellbeing are common concerns among women, and this research provides compelling evidence for the effectiveness of FMD Nutrition in improving overall health. 

"This study demonstrates the holistic and systemic impact of the Fasting Mimicking Technology affecting cellular rejuvenation from as deep as the inner organ systems to the surface tissue like skin. Together with other published FMD studies in diabetes and cancer, this research further validates that FMD Nutrition is a powerful tool in Lifestyle medicine to improve overall health," said William Hsu, MD, Chief Medical Officer of L-Nutra Inc. 

The researchers recruited 45 female participants, ranging from 35 to 60 years old. The group that used the FMD Nutrition five days per month for three consecutive months had significant improvements in skin hydration as measured by Corneometer, as well as maintenance of skin texture, smoothness and tone evenness, compared to individuals in the standard of care group. Participants also reported significant improvements in feelings of happiness, confidence and empowerment to take control of their health, as well as optimism about the future. 

 "This successful clinical trial is another testimony for the rejuvenative power of the Fasting Mimicking Diet. Our goal is to help everyone live a long and healthy life by keeping our biological age younger than our chronological age. Through this trial, we have demonstrated what many of our ProLon® consumers have reported for years, a healthier looking, glowing skin, which helps people around the world feel happy and confident about their lives," said Joseph Antoun, M.D., Ph.D., CEO and Chairman of L-Nutra Inc.  

About L-Nutra Inc. 

L-Nutra Inc. is a company that is focused on discovering, designing, and commercializing novel nutritional programs with the goal of improving human health and adding more life to human life. Its current commercial products are aimed at promoting wellness and healthy aging. ProLon® is the company's flagship product, which is the first and only clinically tested 5-day FMD Nutrition program designed to allow the body to enter a fasting state while still consuming nutrient-dense foods. L-Nutra also offers ProLon Reset™, a 1-day FMD Nutrition kit, and ProLon Intermittent Fasting Bar®, a nutrition bar designed and clinically tested to support intermittent fasting. The company's Nutrition for Longevity® program offers science-backed, chef-curated meals formulated to address the nutritional deficiencies in commercially grown produce. For more information, visit https://l-nutra.com/.

Contact Information:
William Hsu
Chief Medical Officer
whsu@l-nutra.com
6176554394


Original Source: L-Nutra Reports First-Ever Study Showing ProLon® Improves Skin Health, Happiness, and Confidence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.